Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
Stock Information for Maplebear Inc.
Loading
Please wait while we load your information from QuoteMedia.